Search Results for: program in cellular and molecular medicine
A COVID-19 DNA nanoswitch: A new kind of test for a new kind of virus
When the COVID-19 pandemic shut down research laboratories across the country, several labs at Boston Children’s Hospital geared up, including …Read More
Natural killer cells: Protect the placenta cell but kill the infection
Infections that reach the placenta can lead to spontaneous abortions, intrauterine growth restriction, congenital abnormalities, and premature births. New research …Read More
Two drugs join forces against COVID-19
Two drugs, including one developed by a researcher at Boston Children’s Hospital, inhibit the SARS-CoV-2 virus that causes COVID-19 in …Read More
Trial tests dornase alfa, a cystic fibrosis drug, for severe COVID pneumonia
Boston Children’s Hospital and Brigham and Women’s Hospital will soon begin testing an existing drug, dornase alfa, in patients with …Read More
Disulfiram inhibits inflammatory gatekeeper protein: Could it be helpful in COVID-19?
Inflammation is the alarm system by which cells first respond to potential danger. But in excess, inflammation can be deadly. …Read More
Gasdermin E: A new approach to cancer immunotherapy
Tumors have figured out various ways to prevent the immune system from attacking them. Medicine, for its part, has fought …Read More
Protecting against HIV by tricking the immune system
In making an HIV vaccine, a major goal is to stimulate production of broadly neutralizing antibodies that can fight multiple …Read More
Boosting host immune defenses to treat tuberculosis
Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to …Read More
How new loops in DNA packaging help us make diverse antibodies
Diversity is good, especially when it comes to antibodies. It’s long been known that a gene assembly process called V(D)J …Read More
PET imaging shows if PD-1 cancer immunotherapy is working
PD-1 is a protein on our T cells that normally keeps these immune cells from running amok. A growing number …Read More